BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 27650872)

  • 1. Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis).
    Stading BR; Osorio JE; Velasco-Villa A; Smotherman M; Kingstad-Bakke B; Rocke TE
    Vaccine; 2016 Oct; 34(44):5352-5358. PubMed ID: 27650872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of bats (Eptesicus fuscus) against rabies following topical or oronasal exposure to a recombinant raccoon poxvirus vaccine.
    Stading B; Ellison JA; Carson WC; Satheshkumar PS; Rocke TE; Osorio JE
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005958. PubMed ID: 28976983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to vaccination with a commercial inactivated rabies vaccine in a captive colony of Brazilian free-tailed bats (Tadarida brasiliensis).
    Turmelle AS; Allen LC; Schmidt-French BA; Jackson FR; Kunz TH; McCracken GF; Rupprecht CE
    J Zoo Wildl Med; 2010 Mar; 41(1):140-3. PubMed ID: 20722268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of vampire bats using recombinant vaccinia-rabies virus.
    Aguilar-SetiƩn A; Leon YC; Tesoro EC; Kretschmer R; Brochier B; Pastoret PP
    J Wildl Dis; 2002 Jul; 38(3):539-44. PubMed ID: 12243138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raccoon poxvirus as a mucosal vaccine vector for domestic cats.
    Osorio JE; Frank RS; Moss K; Taraska T; Powell T; Stinchcomb DT
    J Drug Target; 2003; 11(8-10):463-70. PubMed ID: 15203914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential effect of prior raccoonpox virus infection in raccoons on vaccinia-based rabies immunization.
    Root JJ; McLean RG; Slate D; MacCarthy KA; Osorio JE
    BMC Immunol; 2008 Oct; 9():57. PubMed ID: 18834520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAFETY, IMMUNOGENICITY, AND EFFICACY OF INTRAMUSCULAR AND ORAL DELIVERY OF ERA-G333 RECOMBINANT RABIES VIRUS VACCINE TO BIG BROWN BATS (
    Gilbert AT; Wu X; Jackson FR; Franka R; McCracken GF; Rupprecht CE
    J Wildl Dis; 2020 Jul; 56(3):620-630. PubMed ID: 31895645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein.
    Fekadu M; Shaddock JH; Sumner JW; Sanderlin DW; Knight JC; Esposito JJ; Baer GM
    J Wildl Dis; 1991 Oct; 27(4):681-4. PubMed ID: 1758034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdovirus-based vaccine platforms against henipaviruses.
    Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
    J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein.
    Esposito JJ; Knight JC; Shaddock JH; Novembre FJ; Baer GM
    Virology; 1988 Jul; 165(1):313-6. PubMed ID: 3291388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife.
    Faber M; Dietzschold B; Li J
    Zoonoses Public Health; 2009 Aug; 56(6-7):262-9. PubMed ID: 19486317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinating the vampire bat Desmodus rotundus against rabies.
    Almeida MF; Martorelli LF; Aires CC; Barros RF; Massad E
    Virus Res; 2008 Nov; 137(2):275-7. PubMed ID: 18761044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model.
    Julander JG; Testori M; Cheminay C; Volkmann A
    Front Immunol; 2018; 9():1756. PubMed ID: 30116244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poxvirus-vectored vaccines for rabies--a review.
    Weyer J; Rupprecht CE; Nel LH
    Vaccine; 2009 Nov; 27(51):7198-201. PubMed ID: 19925953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
    Giel-Moloney M; Rumyantsev AA; David F; Figueiredo M; Feilmeier B; Mebatsion T; Parrington M; Kleanthous H; Pugachev KV
    Vaccine; 2017 Dec; 35(49 Pt B):6898-6904. PubMed ID: 28899628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep.
    DeMartini JC; Bickle HM; Brodie SJ; He BX; Esposito JJ
    Arch Virol; 1993; 133(1-2):211-22. PubMed ID: 8240013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response of cattle to vaccination with commercial modified live rabies vaccines in Guatemala.
    Gilbert A; Greenberg L; Moran D; Alvarez D; Alvarado M; Garcia DL; Peruski L
    Prev Vet Med; 2015 Jan; 118(1):36-44. PubMed ID: 25466762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.